Advanced Biomed Inc Operating Cash Flow
Advanced Biomed Inc (ADVB) reported Operating Cash Flow of -$1.36 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-15
- Advanced Biomed Inc net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$239.78K.
- Advanced Biomed Inc net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$513.56K.
- Advanced Biomed Inc net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$610.34K.
- Advanced Biomed Inc net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$1.54M.
- Advanced Biomed Inc net cash provided by (used in) operating activities for fiscal 2025 was -$5.83M.
- Advanced Biomed Inc net cash provided by (used in) operating activities for fiscal 2024 was -$2.13M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$239.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$753.33K derived: sum of 2 quarters · filed 2026-05-15 | -$1.36M 10-Q · filed 2026-05-15 | -$2.91M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | -$513.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$1.12M 10-Q · filed 2026-02-13 | -$2.67M derived: sum of 3 quarters · filed 2026-02-13 | -$6.08M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-09-30 | -$610.34K 10-Q · filed 2025-11-19 | -$2.15M derived: sum of 2 quarters · filed 2025-11-19 | -$5.56M derived: sum of 3 quarters · filed 2026-05-15 | -$6.41M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$4.95M derived: sum of 2 quarters · filed 2026-05-15 | -$5.80M derived: sum of 3 quarters · filed 2026-05-15 | -$5.83M 10-K · filed 2025-10-08 |
| 2025-03-31 | -$3.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$4.25M derived: sum of 2 quarters · filed 2026-05-15 | -$4.28M 10-Q · filed 2026-05-15 | -$4.76M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$841.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-13 | -$871.52K 10-Q · filed 2026-02-13 | -$1.35M derived: sum of 3 quarters · filed 2026-02-13 | -$2.41M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | -$29.68K 10-Q · filed 2025-11-19 | -$505.51K derived: sum of 2 quarters · filed 2025-11-19 | -$1.57M derived: sum of 3 quarters · filed 2025-11-19 | |
| 2024-06-30 | -$475.83K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | -$1.54M derived: sum of 2 quarters · filed 2025-10-08 | -$2.13M 10-K · filed 2025-10-08 | |
| 2024-03-31 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | -$1.65M 10-Q · filed 2025-05-15 | ||
| 2023-12-31 | -$584.85K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |